Literature DB >> 17084622

Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).

N Bossard1, M Velten, L Remontet, A Belot, N Maarouf, A M Bouvier, A V Guizard, B Tretarre, G Launoy, M Colonna, A Danzon, F Molinie, X Troussard, N Bourdon-Raverdy, P M Carli, A Jaffré, C Bessaguet, E Sauleau, C Schvartz, P Arveux, M Maynadié, P Grosclaude, J Estève, J Faivre.   

Abstract

We present the main results of the first population-based cancers survival study gathering all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/1989 and 31/12/1997 were analysed. Relative survival was estimated using an excess rate model. The evolution of the excess mortality rate over the follow-up period was graphed. The analysis emphasised the effect of age at diagnosis and its variation with time after diagnosis. For breast and prostate cancers, the age-standardised five-year relative survivals were 84% and 77%, respectively. The corresponding results in men and women were 56% versus 58% for colorectal cancer and 12% versus 16% for lung cancer. For some cancer sites, the excess mortality rate decreased to low values by five years after diagnosis. For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 17084622     DOI: 10.1016/j.ejca.2006.07.021

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

Review 1.  Challenging treatment decision-making in older urologic cancer patients.

Authors:  Guillaume Ploussard; Gilles Albrand; François Rozet; Hervé Lang; Elena Paillaud; Pierre Mongiat-Artus
Journal:  World J Urol       Date:  2013-08-30       Impact factor: 4.226

2.  Retinoid acid receptors in human colorectal cancer: An unexpected link with patient outcome.

Authors:  Aurélie Perraud; Michelle Nouaille; Hussein Akil; Daniel Petit; François Labrousse; Marie-Odile Jauberteau; Muriel Mathonnet
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

3.  Oral metronomic cyclophosphamide in elderly with metastatic melanoma.

Authors:  Estelle Borne; Eve Desmedt; Alain Duhamel; Xavier Mirabel; Véronique Dziwniel; Cyril Maire; Valérie Florin; Véronique Martinot; Nicolas Penel; Sophie Vercambre-Darras; Laurent Mortier
Journal:  Invest New Drugs       Date:  2009-08-12       Impact factor: 3.850

4.  Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost?

Authors:  Jean-Michel Cayuela; Elizabeth Macintyre; Meryl Darlington; Raouf Ben Abdelali; Xavier Fund; Patrick Villarese; Michel Tulliez; Emmanuel Raffoux; François Sigaux; Delphine Réa; Valerie Seror
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

5.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

6.  Comparison of power Doppler ultrasound with gray scale transrectal ultrasound in predicting cancer positive prostate biopsy cores.

Authors:  Turgay Kahraman; Rahmi Cubuk; Orhun Sinanoglu; Nuri Tasalı; Mumtaz Ozarar; Bulent Saydam
Journal:  Eurasian J Med       Date:  2010-08

7.  Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?

Authors:  Theodora Bejan-Angoulvant; Anne-Marie Bouvier; Nadine Bossard; Aurelien Belot; Valérie Jooste; Guy Launoy; Laurent Remontet
Journal:  Eur J Epidemiol       Date:  2008-02-09       Impact factor: 8.082

8.  Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models.

Authors:  Coraline Danieli; Nadine Bossard; Laurent Roche; Aurelien Belot; Zoe Uhry; Hadrien Charvat; Laurent Remontet
Journal:  Biostatistics       Date:  2017-07-01       Impact factor: 5.899

9.  A multisource approach to improving epidemiologic estimates: application to global B-cell malignancies.

Authors:  Meghan E Mitchell; Kimberly Lowe; Jon Fryzek
Journal:  ISRN Oncol       Date:  2012-12-31

10.  Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome.

Authors:  Ofer Purim; Noa Gordon; Baruch Brenner
Journal:  Med Sci Monit       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.